Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide

Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide

Critical adverse effects and frequent administration, three times per day, limit the use of flutamide (FLT) as a chemotherapeutic agent in the treatment of prostate cancer. Therefore, our research aimed to develop new cholesterol-based nanovesicles for delivering FLT to malignant cells in an endeavo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed A. Ali, Magdy I. Mohamed, Mohamed A. Megahed, Tamer M. Abdelghany, Khalid M. El-Say
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Draper–Lin small composite design
ex vivo intestinal permeation
flutamide
in vitro cytotoxicity
optimization
in vivo pharmacokinetics
Pharmacy and materia medica
RS1-441
Online Access:https://doaj.org/article/621b646d5c7547c599b4375d12f03a30
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items